47.74
+1.28
+(2.76%)
At close: 7:14:13 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 10 | 9 |
Avg. Estimate | 22.07B | 23B | 88.31B | 90.05B |
Low Estimate | 20.27B | 22.29B | 82.81B | 83.05B |
High Estimate | 24.55B | 24.67B | 98.93B | 101.55B |
Year Ago Sales | 21.85B | 22.25B | 85.53B | 88.31B |
Sales Growth (year/est) | 1.02% | 3.36% | 3.25% | 1.97% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0JQQ.L | -- | -- | -- | -- |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Upgrade | B of A Securities: Underperform to Neutral | 4/15/2025 |
Maintains | Citigroup: Neutral to Neutral | 4/15/2025 |
Maintains | Barclays: Underweight to Underweight | 2/24/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/11/2025 |
Maintains | B of A Securities: Underperform to Underperform | 2/11/2025 |
Maintains | BMO Capital: Market Perform to Market Perform | 2/5/2025 |